Differential sensitivity to Arg side chain modification of IL-1 beta binding to type I and type II receptors

The central role of interleukin-1 (IL-1) in several disease processes, including fever and inflammation, makes the characterization of ligand-receptor interaction of prime importance. The role of arginine (Arg) side chains of hr-IL-1 beta in receptor recognition was studied by the modification of Ar...

Full description

Saved in:
Bibliographic Details
Published in:Agents and Actions Vol. 41; no. 1-2; pp. 105 - 107
Main Authors: Tömösközi, Z, Bugovics, G, Koncz, S, Arányi, P
Format: Journal Article
Language:English
Published: Switzerland 01-03-1994
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The central role of interleukin-1 (IL-1) in several disease processes, including fever and inflammation, makes the characterization of ligand-receptor interaction of prime importance. The role of arginine (Arg) side chains of hr-IL-1 beta in receptor recognition was studied by the modification of Arg residues with the specific reagent 1,2-cyclohexanedione. It was found that chemical modification of Arg residues decreased the binding potential of IL-1 beta to type I receptor dramatically (by 230-fold) while the affinity to type II receptor was reduced only moderately (by 10-fold), with an insignificant reduction of the dissociation rate. These studies suggest that intact Arg side chains of IL-1 beta may be necessary for high affinity binding to type I IL-1 receptor, but have less importance for the interaction of IL-1 beta with type II IL-1 receptor. This observation may be useful in the study of type II IL-1 receptor-mediated biological responses and design of receptor-subtype specific ligands as well.
AbstractList The central role of interleukin-1 (IL-1) in several disease processes, including fever and inflammation, makes the characterization of ligand-receptor interaction of prime importance. The role of arginine (Arg) side chains of hr-IL-1 beta in receptor recognition was studied by the modification of Arg residues with the specific reagent 1,2-cyclohexanedione. It was found that chemical modification of Arg residues decreased the binding potential of IL-1 beta to type I receptor dramatically (by 230-fold) while the affinity to type II receptor was reduced only moderately (by 10-fold), with an insignificant reduction of the dissociation rate. These studies suggest that intact Arg side chains of IL-1 beta may be necessary for high affinity binding to type I IL-1 receptor, but have less importance for the interaction of IL-1 beta with type II IL-1 receptor. This observation may be useful in the study of type II IL-1 receptor-mediated biological responses and design of receptor-subtype specific ligands as well.
Author Arányi, P
Koncz, S
Tömösközi, Z
Bugovics, G
Author_xml – sequence: 1
  givenname: Z
  surname: Tömösközi
  fullname: Tömösközi, Z
  organization: Institute for Drug Research, Budapest, Hungary
– sequence: 2
  givenname: G
  surname: Bugovics
  fullname: Bugovics, G
– sequence: 3
  givenname: S
  surname: Koncz
  fullname: Koncz, S
– sequence: 4
  givenname: P
  surname: Arányi
  fullname: Arányi, P
BackLink https://www.ncbi.nlm.nih.gov/pubmed/8079812$$D View this record in MEDLINE/PubMed
BookMark eNpFkEtLAzEUhYNUalvduBeyFkZvHjOTLGu1OlBwo-BuyORRI21mSKLQf29Li67ugfuds_imaBT6YBG6JnBHAOr7hyUQKSoO9RmaEE6hkCA-RmgCUJUFp1JeoGlKXwBlSQQZo7GAWgpCJ2jz6J2z0Ybs1QYnG5LP_sfnHc49nsc1Tt5YrD-VD3jbG--8Vtn3AfcON6uC4M5mhTsfjA_rQyfvBosbrII5xQZHq-2Q-5gu0blTm2SvTneG3pdPb4uXYvX63Czmq0JTTnLBXNlRLqmpqHKmdoI5Xruqc67kSjKmbQXMEGkYUcpoQwmBipVcdPsXOMVm6Pa4q2OfUrSuHaLfqrhrCbQHY-2_sT18c4SH725rzR96UsR-AZpVZ_8
Cites_doi 10.1016/0167-4838(91)90437-5
10.1093/clinids/6.1.51
10.1016/0014-5793(87)80307-1
10.1111/j.1432-1033.1986.tb10066.x
10.1016/S0021-9258(19)41933-9
10.1016/S0021-9258(19)39265-8
10.1016/0008-8749(81)90034-4
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
DOI 10.1007/BF01986407
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1420-908X
EndPage 107
ExternalDocumentID 10_1007_BF01986407
8079812
Genre Journal Article
GroupedDBID .55
.GJ
23M
28-
29~
40D
40E
41~
53G
5GY
5QI
5RE
95-
95.
95~
ACGFS
AEFIE
ALMA_UNASSIGNED_HOLDINGS
AMKLP
ASPBG
AVWKF
AZFZN
BBWZM
CGR
CS3
CUY
CVF
ECM
EIF
F5P
KOW
M4Y
N2Q
NPM
NU0
QOK
R4E
RHV
ROL
SBY
SDE
SDH
SOJ
TSV
WH7
WK6
X7M
ZGI
ZXP
~EX
AAYXX
CITATION
ID FETCH-LOGICAL-c241t-3f5b2492d62afd7f83f47f6bff54a933ce603d19d31aadcd211063548b3ce0fa3
ISSN 0065-4299
IngestDate Fri Aug 23 02:00:41 EDT 2024
Fri Feb 23 03:46:02 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1-2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c241t-3f5b2492d62afd7f83f47f6bff54a933ce603d19d31aadcd211063548b3ce0fa3
PMID 8079812
PageCount 3
ParticipantIDs crossref_primary_10_1007_BF01986407
pubmed_primary_8079812
PublicationCentury 1900
PublicationDate 1994-Mar
1994-3-00
PublicationDateYYYYMMDD 1994-03-01
PublicationDate_xml – month: 03
  year: 1994
  text: 1994-Mar
PublicationDecade 1990
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Agents and Actions
PublicationTitleAlternate Agents Actions
PublicationYear 1994
References V. B. Nanduri (BF01986407_CR2) 1991; 1118
P. Wingfield (BF01986407_CR7) 1986; 160
C. A. Dinarello (BF01986407_CR1) 1984; 6
L. Patthy (BF01986407_CR5) 1975; 250
BF01986407_CR6
J. J. Huang (BF01986407_CR3) 1987; 223
L. J. Rosenwasser (BF01986407_CR8) 1981; 63
D. Boraschi (BF01986407_CR9) 1992
L. Gehrke (BF01986407_CR4) 1990; 265
References_xml – volume: 1118
  start-page: 25
  year: 1991
  ident: BF01986407_CR2
  publication-title: Biochem. Biophys. Acta
  doi: 10.1016/0167-4838(91)90437-5
  contributor:
    fullname: V. B. Nanduri
– volume: 6
  start-page: 51
  year: 1984
  ident: BF01986407_CR1
  publication-title: Rev. Infect. Dis.
  doi: 10.1093/clinids/6.1.51
  contributor:
    fullname: C. A. Dinarello
– start-page: 19
  volume-title: Neuroimmunology of Fever
  year: 1992
  ident: BF01986407_CR9
  contributor:
    fullname: D. Boraschi
– volume: 223
  start-page: 294
  year: 1987
  ident: BF01986407_CR3
  publication-title: FEBS Lett.
  doi: 10.1016/0014-5793(87)80307-1
  contributor:
    fullname: J. J. Huang
– volume: 160
  start-page: 491
  year: 1986
  ident: BF01986407_CR7
  publication-title: Eur. J. Biochem.
  doi: 10.1111/j.1432-1033.1986.tb10066.x
  contributor:
    fullname: P. Wingfield
– volume: 250
  start-page: 557
  year: 1975
  ident: BF01986407_CR5
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(19)41933-9
  contributor:
    fullname: L. Patthy
– volume: 265
  start-page: 5922
  year: 1990
  ident: BF01986407_CR4
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(19)39265-8
  contributor:
    fullname: L. Gehrke
– ident: BF01986407_CR6
– volume: 63
  start-page: 134
  year: 1981
  ident: BF01986407_CR8
  publication-title: Cell. Immunol.
  doi: 10.1016/0008-8749(81)90034-4
  contributor:
    fullname: L. J. Rosenwasser
SSID ssj0055181
ssj0008282
Score 1.3626786
Snippet The central role of interleukin-1 (IL-1) in several disease processes, including fever and inflammation, makes the characterization of ligand-receptor...
SourceID crossref
pubmed
SourceType Aggregation Database
Index Database
StartPage 105
SubjectTerms Arginine - chemistry
Arginine - metabolism
Binding Sites
Cloning, Molecular
Humans
Interleukin-1 - chemistry
Interleukin-1 - metabolism
Macrophages - metabolism
Radioligand Assay
Receptors, Interleukin-1 - metabolism
Recombinant Proteins - metabolism
Title Differential sensitivity to Arg side chain modification of IL-1 beta binding to type I and type II receptors
URI https://www.ncbi.nlm.nih.gov/pubmed/8079812
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9swFBZp-7KXsW4r6y5F0LUvqYsVy7dHN0lXswuBZtDupdiyFcKYXZpkkP6s_ZD9pp0jybKzvnQPe7GNIgmi83FuOhdC3otYYOhk5ri54A5nA-HEYGg5oSeFx4JcCOXvuLgMv1xFozEf93pN66d27L9SGsaA1pg5-w_UtpvCAHwDzeEJVIfno-g-Mh1PlioTBMPTTX8IUDKTu1kf23Niuu-8wi44GChklcb0k8OOhuOjs0E_n-tsF9RM0Umb6khL9Zn2gUuWt9imp6vaJjOVLIfzEtG6AdErgLfxZ8EP_Vp81-97FUfwrXXTr2b1TxO29ME6-j_WlVA-7svTFpvqdp9Va7XD5LT1XOgSxE3oVsONA99BeahlkWbAHMzZ2FXthi2H5qyLRJMuqRkuc_2O7DYddB-IBbcJdmdYjV5P2qy9_ZdMtJGKTVXndu0W2RkAUwOeupNcXV-PrNwH29VWLsM6d7pZo_mLm5VxzVYbutCGVaO0m-kz8tSYJTTReNolvbJ6To4nuq75-oRO2zS9xQk9ppO24vn6BZl3QUc7oKPLGvacUQQdVaCjXdDRWlIE3e9f1AAOFyDKaEoBSOYzpRZwL8nX8_F0eOGYHh6OAN1w6XjSz7EoZREMMlmEMvIkD2WQS-nzDE5RlIHrFSwuPJZlhSjQHwE6MI9y-MmVmbdHtqu6Kl8R6rqSSVGEOSjV3I_jnLMSr-WFCKIIJu-Tw-Y0b251qZabh-TbJ3v6oO2cyA1jUHNfP2r5G_KkhfJbsr28W5XvyNaiWB0YPByASTb8_AfZSIg6
link.rule.ids 315,782,786,27933,27934
linkProvider Springer Nature
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differential+sensitivity+to+Arg+side+chain+modification+of+IL-1%CE%B2+binding+to+type+I+and+type+II+receptors&rft.jtitle=Agents+and+Actions&rft.au=T%C3%B6m%C3%B6sk%C3%B6zi%2C+Zs&rft.au=Bugovics%2C+Gy&rft.au=Koncz%2C+S.&rft.au=Ar%C3%A1nyi%2C+P.&rft.date=1994-03-01&rft.issn=0065-4299&rft.eissn=1420-908X&rft.volume=41&rft.issue=1-2&rft.spage=105&rft.epage=107&rft_id=info:doi/10.1007%2FBF01986407&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_BF01986407
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0065-4299&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0065-4299&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0065-4299&client=summon